Koolen, Stijn L. W.
Erasmus MC · Erasmus MC Cancer Institute
3 papers on CoChatORCID 0000-0002-0973-7530
Most cited papers
- Verified
Development of [225Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC
Hooijman, E. L., Chalashkan, Y., Ling, S. W., Kahyargil, F. F., Segbers, M., Bruchertseifer, F., Morgenstern, A., Seimbille, Y., Koolen, S. L. W., Brabander, T., et al. (2021) · Pharmaceutics
Radiopharmaceutical Chemistry and ApplicationsChemical Reactions and Isotopes
Cited by 59
- Verified
Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma
Hurkmans, D. P., Jensen, C., Koolen, S. L. W., Aerts, J., Karsdal, M. A., Mathijssen, R. H. J., & Willumsen, N. (2020) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 49
- Verified
Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib
Ernst, S. M., van Marion, R., Atmodimedjo, P. N., de Jonge, E., Mathijssen, R. H. J., Paats, M. S., de Bruijn, P., Koolen, S. L., von der Thüsen, J. H., Aerts, J. G. J. V., et al. (2024) · Journal of Thoracic Oncology
Lung Cancer Treatments and MutationsCancer Genomics and Diagnostics
Cited by 24
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free